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Abstract 
 
Trichomonas vaginalis is a flagellated extracellular protozoan parasite that causes 
Trichomoniasis, a chronic infection in the vaginal and prostate epithelium of humans. 
Current treatments combating T. vaginalis infections are effective but there is a trend 
of increasing resistance to 5- nitromidazoles which are the main class of drugs used to 
treat trichomoniasis. To date, the majority of research has focused on the parasite and 
little research has involved the host. Parasites cannot live without their host which 
suggests that the host must be contributing something other than just a refuge for the 
parasite. This project studies T. vaginalis host–parasite interactions, specifically with 
the aim to identify how host proteins may be involved in the establishment and 
maintenance of T. vaginalis infection. The goal of this project was to interact T. 
vaginalis with HeLa mammalian cervical epithelial cells, with the view to identify 
upregulated and downregulated proteins using sequential window acquisition of all 
theoretical fragment ion spectra (SWATH) proteomics. A proof of principle study was 
also undertaken by knocking out the host receptor galectin-1 using CRISPR/Cas9 
technology. Our hypothesis is that allowing interaction of T. vaginalis with HeLa cells 
there will be potentially a number of upregulated and downregulated host proteins that 
may be manipulated by T. vaginalis, which play a key role in the infection process.  
22 proteins were found to be differentially expressed, including proteins that may be 
manipulated by T. vaginalis. Proteins that were identified were found to have many 
different biological functions including the regulation of apoptosis, inflammation, cell 
cycle regulation and attachment. These proteins may be studied in future experiments 
to identify their biological significance to T. vaginalis infection. The galectin-1 
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knockout study produced a partial knockout of galectin-1 and could be used in future 
attachment studies once further optimization of the CRISPR knockout is performed.  
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Introduction 
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1.1 Trichomonas vaginalis overview: prevalence and risk to public 
health  
 
Trichomonas vaginalis is a flagellated extracellular parasite that belongs to the phylum 
Parabasalia. As shown below in Figure 1, T. vaginalis is pear shaped and has a total 
of 5 flagella, one attached by an undulating membrane and 4 freely attached at the top 
of the parasite. T. vaginalis is a pathogenic protozoan resulting in a sexually 
transmitted infection of humans termed trichomoniasis (Kissinger 2015). This 
infection is estimated to infect 190 million people around the world per year (Van Der 
Pol 2007).  
 
T. vaginalis’ sole host is humans, where it resides in the urogenital tract of males and 
females dividing by binary fission (Kusdian & Gould 2014; Maritz et al. 2014). While 
the parasite colonizes both sexes, symptoms of infection occur more often in females 
than in males (Sutton et al. 2007). Trichomoniasis is the most common non-viral 
sexually transmitted infection causing inflammation of the vagina and/or the urethra 
Figure 1. Structural Anatomy of T. vaginalis (Left) showing 4 free flagellae on the 
anterior side, a single flagellum attached by an undulating membrane, as well as a 
single nucleus (Microbe Online, 2016).20s image of free swimming B7RC2 strain 
T. vaginalis (Right) exhibiting the same shape and characteristics as the image on 
the left.  
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often accompanied with discomfort, pain and discharge (Mielczarek & Blaszkowska 
2016).  
 Furthermore, T. vaginalis has also been implicated in a wide variety of health 
problems. Infection with T. vaginalis results in an increased risk of an individual 
acquiring HIV as well as issues associated with infertility and pre-term delivery such 
as low birth weights (Kissinger & Adamski 2013; Mielczarek & Blaszkowska 2016).  
Studies exploring the link between T. vaginalis and HIV have shown that the 
environment of the vagina plays an important role. The relationship between T. 
vaginalis and natural vaginal flora becomes imbalanced, increasing the procurement 
and transmission of HIV (Kissinger & Adamski 2013).  
Due to this parasites ability to attach to 
vaginal epithelial cells, T. vaginalis 
orchestrates a local immune response, 
leading to the inflammation of the vaginal 
epithelium in women and urethral 
epithelium in men. As shown in Figure 2, 
T. vaginalis is passed on by sexual contact 
passed on through vaginal and prostatic 
secretions. When the local immune 
response has begun, the inflammatory 
process disrupts the normal environment 
causing an imbalance of natural flora and 
altering the high pH of the environment to a lower pH. This causes an influx of immune 
cells into the area which potentially allows HIV to enter through lesions created by 
this response should a person have sexual contact with a HIV infected individual 
Figure 2. Life Cycle of T. vaginalis within 
the human host, the parasite multiplies by 
binary vision and is passed on by vaginal 
and prostatic secretions (CDC,2016). 
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(Kissinger & Adamski 2013). Furthermore, T. vaginalis causes hemorrhages in the 
mucosal membrane which increases the likelihood of HIV to be able to pass this 
protective barrier (McClelland et al. 2007).  
The risk of developing cervical and prostate cancers is also increased, with one study 
showing a 3-fold increase of the detection of T. vaginalis in patients suffering from 
cervical cancer, although the mechanism behind this association is yet to be explored 
(Fowke et al. 2016; Sayed el-Ahl et al. 2002; Stark et al. 2009; Zhang, ZF et al. 1995). 
Studies considering the association of T. vaginalis and prostate cancer have linked 
chronic T. vaginalis infections with an increase in prostate cancer via T. vaginalis 
macrophage migration inhibitory factor (TvMIF). TvMIF acts similarly to its human 
counterpart, Human macrophage inhibitory factor (HuMIF) which has been shown to 
have a role in prostate cancer. TvMIF causes inflammation that triggers the 
proliferation of cells which promotes prostate cancer development (Twu et al. 2014). 
Currently the standard treatment for T. vaginalis infections is to treat with 5-
nitroimidazoles such as the FDA approved metronidazole which is taken orally 500 
mg twice a day for seven days or as a single 2g dose (Howe & Kissinger 2017). 
However, there has been a small increase at 5% in resistance to this drug leading to 
higher morbidity and relapsed infections which may mean there are host factors at play 
(Dunne et al. 2003; Kissinger 2015). This is further contended by the fact that infection 
by T. vaginalis is often underdiagnosed which is a big concern due to the important 
unfavourable health implications stated above (Javanbakht et al. 2013; Kissinger 2015; 
Wangnapi et al. 2015). Often when T. vaginalis is diagnosed and treated, re-infection 
will occur due to sexual contact with a partner who has not been treated for T. 
vaginalis. Due to this trend, prevention is extremely important as a person can 
immediately become re-infected (Alcaide et al. 2016; Hillier 2013; Kanno & Sobel 
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2003). Collectively, the increased prevalence of T. vaginalis, the trend of undiagnosed 
cases, the ease of reinfection and a small rise in metronidazole resistance poses great 
implications to public health around the world.  More research must be performed on 
this parasite in order to improve public health outcomes in the future.  
1.2 T. vaginalis pathogenicity: Molecular overview and host parasite 
interaction studies  
 
In the study of parasitology, the focus of research efforts has been placed on the 
parasite while the host is often neglected. It is a possibility that by overlooking the 
contribution of the host to this interaction we are potentially restricting the amount of 
knowledge available. As the parasite requires the host to survive, it is imperative to 
understand what the host is contributing to the relationship. Perhaps by studying the 
host’s contribution we will reveal a more holistic and clearer picture of the host and 
parasitic relationship and identify key areas that could lead to a potential cure. There 
have been T. vaginalis host – parasite interaction studies that have examined the role 
of parasite adhesion to host cells. These studies have focused on the roles of parasite 
surface proteins and molecules such as T. vaginalis lipoglycan (TvLG) which binds to 
host cell surface receptors (Ryan, de Miguel & Johnson 2011).  Studies have also 
shown that when T. vaginalis interacts directly with host vaginal epithelial cells, they 
attach, shrink and change shape from their regular flagellated trophozoite state to a 
more rounded ameboid shape (Lin, WC et al. 2015; Petrin, Dino et al. 1998). Many 
studies have also explored T. vaginalis molecular mechanisms through host parasite 
interaction studies which have greatly increased our understanding of the parasite. 
Research has shown that T. vaginalis is able to manipulate its host environmental niche 
in order to initiate the inflammatory response which may help trick the immune system 
in increasing the parasites ability to survive within its host. T. vaginalis selectively 
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upregulates molecules such as proinflammatory mediators; cytokines, IL-8, IgA, IgG 
and Th1 that mediate the immune response (Fichorova 2009). T. vaginalis is able to 
suppress the immune response via adhesins such as AP65 and cysteine proteases 
(CP30) in order to induce apoptosis and suppress cytokines such as IL-10, TGFβ 
(Chang et al. 2004; Mundodi et al. 2004 ). T. vaginalis suppresses IL-10, TGFβ, 
monocytes and macrophages in order to avoid detection and destruction (Chang et al. 
2004; Fichorova 2009). Combined, it seems that T. vaginalis selectively induces and 
suppresses immune responses to manipulate the immune system in to destroying host 
cells, which aids T. vaginalis in gaining nutrients from the microenvironment while 
also avoiding destruction via cytokines.  
Furthermore, T. vaginalis is able to phagocytose epithelial cells and bacteria in order 
to gain the essential nutrients it needs to survive and replicate (Petrin, Dino et al. 1998). 
T. vaginalis actively releases an array of secretory proteins, some that aid T. vaginalis 
in adhering (adhesins) and others to break down proteins (proteases). These secreted 
proteins include lipophosphoglycan (LPG), adhesins, cysteine proteases and 
cytoskeletal proteins (Hernández, Marcet & Sarracent 2014). T. vaginalis LPG directly 
interacts with host galectin–1, a surface receptor located on the surface of epithelial 
cells, triggering interleukin 8 expression and facilitating parasite adhesion (Lin, W-C 
et al. 2015).   
Through the use of adhesins, T. vaginalis anchors itself to host epithelial cells and to 
facilitate the uptake of iron in the environment. This is needed in order to facilitate 
growth as T. vaginalis requires iron as a key component in its metabolism, for example 
as a cofactor in enzymes and regulatory proteins (Beltrán et al. 2013; Lehker & 
Alderete 1992). T. vaginalis has been seen to regulate genes when environmental iron 
is limited. It responds to such environments by upregulating hydrogesomal iron sulfur 
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cluster proteins while downregulating enzymes used in carbohydrate metabolism such 
as Fe-Fe hydrogenase and pyruvate ferredoxin oxidoreductase (PFO) (Beltrán et al. 
2013). This shows that T. vaginalis is able to differentially express genes in direct 
response to their environment increasing its survivability for example, in the vaginal 
region where iron availability constantly changes. Other proteins such as adhesin 
proteins AP23, AP33, AP51 and AP65 have been found to be synthesized by T. 
vaginalis enabling the parasite to acquire iron from its host (Garcia et al. 2003). 
Surface AP65 expressed from T. vaginalis is able to adhere to erythrocytes enabling 
iron to be taken into the parasite (Vieira et al. 2015). Increased expression of T. 
vaginalis surface adhesins was demonstrated to occur following contact with vaginal 
epithelial cells which suggests a contact dependent mechanism for adherence at play 
(Garcia et al. 2003).  
Several studies have explored this host–parasite interaction through co-culture 
methods and have discovered that T. vaginalis is capable of altering gene expression 
in host cells. Specifically, those involved in the immune response resulting in 
differential expression of host cytokines IL-1α and IL-1β (Kucknoor, Mundodi & 
Alderete 2005). IL-1β mediates inflammatory responses and increases tight junction 
permeability (Lin, W-C et al. 2015). Tight junctions aid in the communication between 
adjacent cells and the disruption of these junctions can affect macromolecule 
trafficking and trigger an inflammatory response which allows T. vaginalis to uptake 
the nutrients it needs to survive and proliferate (Lee 2015).  
While T. vaginalis employs contact dependent mechanisms for attachment, nutrient 
uptake, survival and proliferation, T. vaginalis also utilizes contact independent 
mechanisms concurrently. Contact independent mechanisms include the secretion of 
enzymes such as cysteine proteases. Cysteine proteases (CPs) are an important class 
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of enzymes secreted and utilized by T. vaginalis to break down host proteins and 
assists in parasite adherence. These enzymes have been implicated in parasite 
cytotoxicity, adherence, metabolism, haemolysis and evasion of the immune response 
(Hernández, Marcet & Sarracent 2014). One study by Mendoza- Lopez et al (2000) 
showed that cysteine proteases such as CP30, a key virulence factor, is used by the 
parasite in order to bind to the surface of mammalian cervical epithelial cells, but is 
only partly responsible for parasite attachment (Mendoza-Lopez et al. 2000). Cysteine 
proteases can counter host immune responses by degrading IgG and IgA, dampening 
the humoral immune response further aiding parasite survival (Provenzano & Alderete 
1995). Through host–parasite interaction studies using the cysteine protease inhibitor 
E-64, cysteine proteases have been identified as T. vaginalis virulence factors, such 
virulence factors including CP4, CP12, CP39 (Figueroa-Angulo et al. 2012).  
The genome of T. vaginalis was published in 2007 which has been an extremely useful 
tool in understanding the underlying molecular mechanisms of this parasite (Carlton, 
J.M. et al. 2007). The genome contains 446 proteases, of which 220 are cysteine 
proteases (Carlton, J. M. et al. 2007).  T. vaginalis has one of the largest genomes of a 
protist sequenced. The genome is 160 Mb and has been suggested to encode for around 
46,000 unique proteins (Smith & Johnson 2011). The genome also provided insights 
into the evolutionary pathways of T. vaginalis. T. vaginalis was found to have 
expanded its genome size significantly, especially the parasites membrane trafficking 
machinery. This expansion or duplication of genes is used to secrete proteins that have 
capabilities including the ability to endocytose host proteins, phagocytose host cells as 
well as bacteria. This has improved T. vaginalis’ ability to adapt to its host’s 
environment (Carlton, Jane M. et al. 2007). The genome of T. vaginalis also consists 
of 152 genes that have been inherited through lateral gene transfer from prokaryotes, 
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which may have also aided T. vaginalis adaption to its environment which it shares 
with several prokaryote species (Carlton, Jane M. et al. 2007). One such gene that may 
have been acquired through lateral gene transfer encodes for the enzyme N-
acetylneuraminate lyase. This enzyme metabolises sialic acids which has been 
identified to be similar in different organisms and allows these organisms to acquire 
sialic acid from its host environment (Singh, S et al. 2012). 
Studies have considered the effects of host environmental factors on the virulence of 
T. vaginalis and have identified several factors that modulate the expression of genes 
in the parasite (Figueroa-Angulo et al. 2012).  Regulation by iron was identified as an 
important contributor to differential gene expression, which is essential for growth and 
metabolism. Given that T. vaginalis survives on the cervical epithelium, T. vaginalis 
must adapt to an environment that is constantly changing due to the menstrual cycle. 
Interestingly, trichomoniasis symptoms have been observed to be more severe during 
the menstrual cycle where there is a higher pH and the menstrual blood supplies a rich 
amount of iron for the parasite to utilize (Cudmore et al. 2004; Petrin, D. et al. 1998).  
1.3 Role of galectin–1 in T. vaginalis adhesion to mammalian cells 
 
Galectin–1 is a host β-galactoside binding protein that binds lectins, which is encoded 
by the gene LGALS1. Galectin-1 is found on the cell surface of human epithelial cells 
and is part of a larger family of galectins which have diverse biological roles (Liu & 
Rabinovich 2010).  Galectins are able to mediate interactions between cells and can 
also cross link to each other in order to facilitate adhesion through the binding to 
glycans on neighboring cells (Zick et al. 2004). Galectins have been implicated in 
many diseases including HIV, cancer and chronic inflammation (Curciarello et al. 
2014; Zhang, P et al. 2014). Studies have suggested a role for host galectin-1 and 
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galectin-3 in T. vaginalis pathogenicity, acting as pathogen recognition receptors to T. 
vaginalis LPG (Fichorova, R. N. et al. 2016).  Host galectin–1 and 3 were silenced via 
siRNA in a host-parasite interaction study which found that silencing galectin-1 
suppressed chemokine responses to T. vaginalis. On the other hand, silencing galectin-
3 reduced immune responses, such as IL-8 responses to T. vaginalis LPG (Fichorova, 
R. N. et al. 2016). T. vaginalis could reduce extracellular levels of galectin-3 as well 
as bind to galectin-1 to reduce chemokine expression (Fichorova, R. N. et al. 2016).  
Due to the morphology of T. vaginalis, LPG covers the surface of this parasite which 
contains a large amount of galactose. This galactose can be recognized and bound by 
host cell galectins and may possibly facilitate the establishment of infection. T. 
vaginalis LPG is able to attach to host cell galectin through cross linking of the glycan 
to host galectin (Singh, BN et al. 2009). This implies that host surface galectin-1 plays 
a vital role in parasite adherence (Okumura, Baum & Johnson 2008). The same study 
that silenced host cell galectin -1 using siRNAs found that reducing the expression of 
galectin-1 negatively impacted the ability for T. vaginalis to bind to host epithelial 
cells (Okumura, Baum & Johnson 2008; Vasta et al. 2012).  
When combining this information about the role of galectins, in particular galectin-1, 
we can see that there are potentially multiple roles of galectin that T. vaginalis exploits 
in order to survive and proliferate in its niche environment. These roles include parasite 
attachment and evasion of the immune system through suppressing chemokines and 
IL-8 responses. This suggests that galectins such as galectin-1 should be considered to 
be prime targets for further study to determine how important host galectins are and if 
they could potentially act as novel targets for therapies in the future.  
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1.4 CRISPR gene knockout study  
 
Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR 
associated protein 9 (Cas9) is a gene editing system derived from the natural defence 
systems of bacteria such as Streptococcus pyogenes which can be used to induce a 
mutation in target DNA thereby knocking the corresponding gene out (Munoz et al. 
2014). CRISPR is a relatively new technology which was discovered and developed 
by multiple scientists around the world since 1993 but it took until 2013 to be used as 
a genome editing technique (Lander 2016).  As this technology is still relatively young, 
the potential impact of this extremely precise and cost-efficient technology is still 
being debated, especially in the context of the ethics of human genome editing (Go & 
Stottmann 2016). The hope is that CRISPR could be used in the future to treat 
numerous diseases, especially genetic diseases such as cystic fibrosis, down syndrome 
and sickle cell anemia (Go & Stottmann 2016).   
Currently CRISPR/cas9 systems have been mainly used on mammalian and plant 
genomes, with some studies expanding into eukaryotes such as Toxoplasma gondii in 
order to gain further understanding on the function of specific genes within the 
parasites genome (Sidik et al. 2014).  The ability to genetically engineer parasites such 
as T. gondii using CRISPR/ cas9 is still quite new and yet CRISPR has been shown to 
be an efficient tool for genome editing (Sidik et al. 2014). CRISPR has also been 
successfully used in Plasmodium falciparum and Leishmania donovani providing 
functional analysis of genomes, improving and increasing the efficiency of research 
into the function of genes in these parasites (Ghorbal et al. 2014; Zhang, WW & 
Matlashewski 2015). Currently there have been no published studies using CRISPR in 
T. vaginalis, which would be imperative in further understanding the function and 
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discovery of key genes in this parasite. Despite CRISPR/cas9 gene editing has not been 
utilised in T. vaginalis, CRISPR gene editing may potentially be used to identify 
functional relations between T. vaginalis and host cells during interaction studies. By 
editing genes in host mammalian epithelial cells, novel insights into the function and 
roles of proteins such as galectin-1 in mammalian cells may be discovered. In this 
thesis, galectin-1 was attempted to be knocked out as a proof of concept study, to 
further analyse the role of host surface galectin-1 on the adherence of T. vaginalis in 
future studies.    
Although there are various CRISPR/Cas9 systems, the system that will be used in this 
study contains dual nickases that cause breaks in both strands of DNA at specific target 
locations. CRISPR uses single guide RNA to target a specific sequence as well as a 
scaffold domain in order to bind Cas9 (DNA endonuclease) (Munoz et al. 2014). The 
guide RNA is complementary to the bases of a specific sequence of DNA of the gene 
that is being targeted for knockout or knockdown, thus enabling the sgRNA to target 
a specific region in the genome. The target DNA must be directly adjacent to a 
protospacer adjacent motif (PAM) in order for Cas9 to successfully bind and cleave 
the DNA (Ran et al. 2013).  Once bound to this DNA sequence the scaffold DNA 
allows Cas9 to specifically target this region of DNA and make cuts, which then 
induces DNA repair mechanisms. Through homologous repair, the target DNA 
mutates leading to the knockdown of the target gene of interest (Munoz et al. 2014). 
Due to the chance of off target mutations, dual Cas9 nickases will be used to nick target 
DNA on both strands. As shown in Figure 3, dual nickases target two specific sites 
which increases the specificity of Cas9 endonuclease activity and reduces the chances 
of off-target mutations occurring (Ran et al. 2013). Figure 4 shows the components of 
the double nickase plasmid supplied by Santa Cruz Biotechnologies (2017). One 
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plasmid in the pair contains a puromycin resistance gene which was used in order to 
select for transfected cells.  
 
Figure 3. CRISPR double nickase diagram showing two target sites of the nickase 
plasmids. The dual nickases target complementary strands of DNA opposite of the 
targeted DNA in order to induce a mutation causing a knockout/down (Santa Cruz, 
2017). 
 
 
Figure 4. Components of a double nickase plasmid, showing the inclusion of a 
puromycin resistance gene to be used for selection as well as a GFP gene that can be 
used for cell sorting (Santa Cruz, 2017). 
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There have been a few studies knocking out genes in the host of T. vaginalis, while 
most have used methods such as siRNA to knockdown the genes. A study considering 
the effects of galectin-1 and galectin-3 expression on T. vaginalis adherence used 
siRNA to knockdown galectin-1 and 3 expression within host epithelial cells. They 
found that reducing galectin-1 and 3 expression correlated to a partial reduction in 
attachment to the host, suggesting that there are multiple factors that contribute to T. 
vaginalis ability to attach to its host (Fichorova, Raina N. et al. 2016). The same 
researchers found that T. vaginalis is able to regulate the availability of galectin in 
order to suppress chemokines and aid the parasites survival (Fichorova, Raina N. et al. 
2016).   
1.5 SWATH-MS proteomic study  
 
Proteins are vital to the function of all living organisms. The global study of proteins, 
proteomics, is a vital technique used to understand the role(s) of proteins within an 
organism. Proteomics is a large-scale study of all proteins in an organism at a given 
point in time, that can provide insights into what proteins are expressed in response to 
a particular stimulus. This data can then be compared to genomic data in order to 
identify the correlated genes. Proteins are the final product of genes which highlights 
why understanding the functions and structure of proteins including post translational 
modifications (PTMs) can provide insights into the phenotype and functional 
characteristics of an organism (Graves & Haystead 2002). Proteomics has been a 
useful tool for many studies including the study of human parasites including T. 
vaginalis. For example, proteomics has been used to identify the abundance of cysteine 
proteases and has contributed to their identification as virulence factors that 
enzymatically break down host proteins (Sommer et al. 2005).  
25 
 
There are numerous methodologies utilized in protein analysis ranging from 2 
dimensional (2D) gels to large scale shot gun proteomics that uses mass spectrometry 
in tandem with liquid chromatography columns to separate and identify proteins. There 
are positives and negatives for all methodologies. For example, 2D gels are able to 
separate individual proteins from complex samples, but require a lengthy manual 
process leading them to be more prone to human error (Bunai & Yamane 2005).  
The methodology used in this study was sequential window acquisition of all 
theoretical mass spectra (SWATH) a type of shotgun proteomics performed at the 
Australian Proteome Analysis Facility (APAF) at Macquarie University. SWATH is a 
label free mass spectrometry based proteomic tool that is able to detect a large amount 
of proteins (> 6000) from the lysates of whole cells (Huang et al. 2015). As shown in 
Figure 5, SWATH uses data independent acquisition in combination with a peptide 
spectral library before statistical analysis is performed. SWATH can be used to 
accurately identify proteins across a wide range of samples, while also quantifying the 
relative abundance of the proteins (Huang et al. 2015).  
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Figure 5. SWATH proteomic workflow at the Australian analysis facility, samples are 
digested with trypsin to break up the proteins into fragments before run through MS, 
a database is searched using the independent data generated by MS, the data is 
statistically analyzed and differentially expressed proteins with a p value of < 0.05 are 
highlighted (APAF, 2010).  
 
SWATH analysis was performed on mammalian HeLa cells following direct 
interaction with T. vaginalis for a defined amount of time. This methodology aimed to 
potentially identify proteins that have become upregulated or downregulated in the 
host cells following T. vaginalis attachment providing a proteome wide scale analysis. 
This potentially generated a knowledge of key proteins and/or pathways used by T. 
vaginalis that could be used in future studies and to develop novel therapies in the 
future.  
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2.1 Aims  
There are two specific aims of this study Aim 1: is to investigate changes in protein 
expression in host mammalian cervical epithelial cells following direct interaction of 
T. vaginalis parasites and HeLa cells. Aim 2: a proof of concept study to successfully 
knockout host galectin-1 using CRISPR/ Cas9 technology. Combined, this study will 
reveal new insights into host–parasite protein–protein interactions gaining further 
understanding of host–parasite interactions.  
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Chapter 3: 
Methods 
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3.1 Culturing methods 
 
3.1.1 Mammalian cell culturing 
HeLa cells (ATCC® CCL-2™) were cultured in vitro at 37°C, 5% CO2 in Dulbeccos 
Modified Eagle’s Medium (DMEM) (D5546-500ML, Sigma-Aldrich) supplemented 
with 10% foetal bovine serum (SFBS-F Bovogen) and a final concentration of 10 
U/mL penicillin and 10 µg/mL (P4333 Sigma-Aldrich) streptomycin antibiotics. HeLa 
cells were passaged at 80% confluency by removing media and washing in pre-
warmed (37°C) phosphate buffered saline (PBS) (D8537-500ML Sigma-Aldrich). 1 
mL of Trypsin-EDTA (0.25%, 0.02%) was added and the cells were placed in a 35°C 
incubator for 5 minutes. Trypsinised cells were placed in a 15 mL tube and spun down 
in a centrifuge at 300 g for 5 minutes. The pellet was washed in fresh DMEM before 
being centrifuged at 300 g and was repeated for an additional 5 minutes. HeLa cells 
were resuspended in fresh DMEM and an aliquot was taken in order to count viability 
using a haemocytometer.  20 µL of cell suspension was mixed with 20 µL of trypan 
blue in a 1:1 ratio, stained and unstained cells were counted in order to count total 
number of viable cells using the formula live cells/ total cells x 100. Cells > 95% 
viability were split at a ratio of 500 µL cells to 4.5 mL DMEM and aliquoted into 
sterile T-25 flasks. 
3.1.2 Parasite culturing 
T. vaginalis strain B7RC2 (ATCC® 50167™) was cultured in Diamonds modified 
medium containing tryptose (211713 BD Biosciences), yeast extract (212750 BD 
Biosciences), maltose (M5895 Sigma-Aldrich), cysteine (C7477 Sigma-Aldrich), 
ascorbic acid (A4544 Sigma-Aldrich), KH2PO4 (0781 Amresco), K2HPO4 (P3786 
Sigma-Aldrich) and pH was adjusted to 6.2 using HCl (302331 Sigma-Aldrich). Media 
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was autoclaved before 10 µg/ ml of iron solution (203505-25G, Sigma-Aldrich) 
consisting of 0.1 g/mL Fe(NH4)2(SO4)6H20 and 0.01 g/mL 5–sulfosalicylic acid 
(0610-250 Amresco) was filter sterilized and added to the media. Media was 
supplemented with 10% heat inactivated horse serum and 1x Penicillin- Streptomycin 
cocktail (P4333-100ML Sigma-Aldrich) prior to parasite incubation.  T. vaginalis was 
grown in an axenic environment in an incubator set at 37°C plus 5% CO2 and passaged 
every 2 days.  Parasite numbers and viability were counted using a haemocytometer 
and parasites were stained in propidium iodide (P4170-10MG, Sigma-Aldrich) to 
check viability of the cells. 1 µL of propidium iodide (1ug/ml) was mixed with 999 
µL of parasites and mixed. 10 µL of propidium iodide/ cell mix was pipetted onto a 
haemocytometer and then placed under a fluorescent microscope. Propidium iodide is 
excluded from live cells and is excited at 535 and has an emission at 617 nm. Live and 
dead cells (stained) are counted to acquire a percentage by the formula: Viable cells 
divided by total cells x 100. All parasites used in each experiment were >95% viable. 
Parasites were not subcultured for more than 6 subcultures before a fresh stock was 
revived in order to maintain the parasites virulence.  
Stocks of T. vaginalis were cryopreserved as per ATCC guidelines within the first two 
subcultures of a revived stock to keep the passage number of parasites as low as 
possible (ATCC, 2017).  
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3.2 Host- Parasite interaction study methods 
 
3.2.1 SWATH-MS Host-parasite interaction  
HeLa cells were grown to 80% confluency in 6 T-25 flasks while B7RC2 strain T. 
vaginalis parasites were cultured as described above and counts were taken using a 
haemocytometer to obtain a concentration of 1 x 106 parasites/ml and > 95% viability 
in a 50 mL Eppendorf tube. Parasites were spun down at 800 g for 5 minutes and 
adjusted to 1 x 106 parasites by resuspending in 1:1 DMM/DMEM.  Confluent HeLa 
cells were washed twice in sterile mammalian culture grade phosphate buffered saline 
and 10 mL of pre-warmed 1:1 DMM/DMEM media mixture was added to the T-25 
flasks. At the start of the interaction 5 x 104 parasites/mL (MOI 1:5) were added to 3 
flasks while 3 control flasks were given extra media equal to the volume of parasites 
to keep the volume of media in the flasks consistent (250 µL equivalent to the amount 
added to the treated flasks equal to 5 x 104 parasites/mL). The flasks were placed in an 
incubator at 37°C plus 5% CO2 for 30 minutes. After 30 minutes, the interaction was 
broken by placing the flasks (including controls) on ice for 10 minutes. The media was 
removed and the cells were washed twice with 5 mL of ice-cold PBS. Between each 
wash, the flasks were lightly hit on the sides (Using hands) in order to aid the 
dislodging of the parasites. Flasks were inspected visually using a microscope between 
each wash to detect if the parasites were washed off completely. The HeLa cells were 
immediately lysed in 200 µL of ice cold lysis buffer (1% SDC (D750 Sigma-Aldrich), 
0.1 M Triethylammonium bicarbonate (T7408 Sigma-Aldrich), 150 mM NaCl (s9888 
Sigma-Aldrich)) + 1x protease inhibitor cocktail (P8340 Sigma-Aldrich) + 10 mM 
NaF (201154 Sigma-Aldrich). HeLa cells were lysed for 1 hour on ice on a shaker 
before the cells were scraped off each flask using a new pre-chilled sterile cell scraper 
for each individual flask. The lysate was transferred to pre-chilled 1.5 mL Eppendorf 
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tubes and spun down to remove bubbles at 10,000 g for 5 minutes at 4°C. The samples 
were then sonicated on ice at 65 ampules 5 seconds on, 15 seconds off and repeated 
for a total sonication time of 35 seconds using a Unisonics fx8 sonicator. The samples 
were then spun down again at 10,000 g for 5 minutes at 4°C and the lysate was 
transferred to new pre-chilled 1.5 mL Eppendorf tubes to remove any cellular debris. 
A BSA protein concentration assay (Bio-Rad detergent compatible) (Bio-Rad DC 
Protein Assay Bio-Rad) used to quantify the total amount of proteins in each sample. 
The protein concentration assay measured triplicates of the samples against seven 
known concentrations of bovine serum albumin: 0, 0.25, 0.5 ,1 ,2 ,3 ,4 mg/ mL in 
triplicate on a 96 well plate. 25 µL of reagent A was pipetted into each well before 5 
µL of each standard and sample (triplicates) were added. 200 µL of reagent B was 
added to make up a total of 230 µL in each well. The plate was placed in darkness for 
15 minutes to allow for the colimetric reaction to occur. The plate was read on a 
spectrophotometer plate reader (ThermoScientific Multiskan® EX) at an absorbance 
of 595 nm. Data collected was analysed using Excel to create a standard curve from 
the standard readings and the Control and treated samples were compared to these 
standards to obtain the relative concentrations of the samples.   
3.2.2 SWATH mass spectrometry  
SWATH mass spectrometry was performed at the Australian Proteome Analysis 
Facility at Macquarie University. The following methods were sent from APAF 
with a report outlining the steps from sample preparation to quantitation (Pages 
33-37).  
3.2.3 Sample Preparation  
50 ug of protein from each sample was diluted using 100 mM TEAB buffer containing 
1% sodium deoxycholate giving a final concentration of 50 µL. Samples were reduced 
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with dithiothreitol (final concentration of 10 mM DTT) for 30 minutes at 56°C 
followed by alkylation with iodoacetamide (final concentration of 25 mM IAA) at 
room temperature for 30 minutes. Samples were digested with 1 µg of trypsin (1 µg 
trypsin per 50 µg of protein) for approximately 16 hours at 37°C. Formic acid was 
added to make a final concentration of 1% to precipitate sodium deoxycholate. 
Samples were centrifuged at 10,000g for 10 min and supernatant containing peptides 
was collected in a fresh tube and dried using vacuum centrifugation.  
Prior to LC-MS analysis, samples were reconstituted using 25 µL of 2% acetonitrile, 
97.9% water and 0.1% formic acid. Sonicated and vortexed briefly followed by high 
speed centrifugation for 10 minutes. Supernatant containing peptides were subjected 
to LC-MS/MS analysis.  
3.2.4 High-reverse-phase fractionation  
A pool of peptides was prepared using approximately 23 µg of each sample (total ~200 
µg) and cleaned up with C18 Sep Pack Light Cartridges (Waters, Millford MA) and 
dried down using a speed-vac. Samples were reconstituted with 5 mM ammonia 
solution (pH 10.5) and loaded onto an Agilent 300 Extend C18 column (2.1 mm x 150 
mm, 3.5 µm, 300Å). Using a 1260 quaternary HPLC system, peptides were separated 
using a linear gradient of 5 mM ammonia solution with 90% acetonitrile (pH 10.5) 
starting from 3% to 30% for 55 minutes, and then to 70% for 10 minutes and finally 
to 90% for another 5 minutes at a flow rate of 300 μL/min. Peptides were separated 
into a total of 90 fractions that were consolidated into 13 for liquid chromatography 
tandem mass spectrometry (IDA-LC–MS/MS) analysis.  
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3.2.5 1D Information dependent acquisition (IDA)  
HpH fractionated peptides were subjected to 1D-IDA nanoLC MS/MS analysis (IDA-
LC–MS/MS). Each sample was injected onto a reverse-phase trap for preconcentration 
and desalted with 2% acetonitrile, 97.9% water and 0.1% formic acid, at 5 µL/min for 
3 minutes. The peptide trap was then switched into line with the analytical column. 
Peptides were eluted from the column using linear solvent gradients of 5-35% of 
mobile phase B over 120 min at a flow rate of 600 nL/min. After peptide elution, the 
column was cleaned with 95% solvent B for 6 minutes and then equilibrated with 95% 
mobile phase A for 10 minutes before next sample injection. The reverse phase nano-
LC eluent was subject to positive ion nano-flow electrospray analysis in an information 
dependent acquisition mode (IDA).  
In the IDA mode, a TOF-MS survey scan was acquired (m/z 350-1500, 0.25 second), 
with the 20 most intense multiply charged ions (2+ to 4+; exceeding 200 counts per 
second) in the survey scan sequentially subjected to MS/MS analysis. MS/MS spectra 
were accumulated for 100 milliseconds in the mass range m/z 100–1800 with rolling 
collision energy.  
3.2.6 Data independent acquisition (SWATH)  
Each sample (2 µg) was injected onto a peptide trap for pre-concentration and desalted 
with 0.1% formic acid, 2% ACN, at 5 µL/min for 3 minutes. The peptide trap was then 
switched into line with the analytical column. Peptides were eluted from the column 
using linear solvent gradients of 5-35% of mobile phase B over 60 min at a flow rate 
of 600 nL/min. After peptide elution, the column was cleaned with 95% mobile phase 
B for 6 minutes and then equilibrated with 95% mobile phase A for 10 minutes before 
next sample injection. The reverse phase nano-LC eluent was subject to positive ion 
nanoflow electrospray analysis in a data independent acquisition mode (SWATH).  
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For SWATH MS, m/z window sizes were determined based on precursor m/z 
frequencies (m/z 400–1250) in previous IDA data (SWATH variable window 
acquisition, 100 windows in total). In SWATH mode, first a TOF-MS survey scan was 
acquired (m/z 350-1500, 0.05 sec) then the 100-predefined m/z ranges were 
sequentially subjected to MS/MS analysis. MS/MS spectra were accumulated for 30 
milliseconds in the mass range m/z 350-1500 with rolling collision energy optimised 
for lowed m/z in m/z window +10%. To minimize instrument condition caused bias, 
SWATH data were acquired in random order for the samples with one blank run 
between every sample injection.  
3.2.7 IDA data analysis  
The 13 data files generated by IDA-MS analysis of HpH fractioned samples were 
searched with ProteinPilot (v5.0) (Sciex) using the ParagonTM algorithm in thorough 
mode. Uniprot (Uniprot_Human_review_Sept_2017, downloaded from 
http://www.uniprot.org/proteomes/UP000005640) database containing 42,202 human 
proteins was used for searching the data. Carbamidomethylation of Cys residues was 
selected as a fixed modification. An unused Score cut-off was set to 1.3 (95% 
confidence for identification). Resultant consolidated data file was used as ion-library 
with further modifications as described in the following section.  
3.2.8 SWATH quantitation  
SWATH data files and ion-library were imported into PeakView (v2.1) software and 
retention times were aligned using six high abundant endogenous peptides. Following 
the retention time alignment, resultant ion library was manually modified to include 
peptides with following most frequently observed modifications; cabamidomethyl (C, 
@N-term), Oxidation (M), dioxidation (W), acetylation proteins N-term, Gln->pyro-
Glu and Glu->pyro-Glu. SWATH data were extracted using PeakView (v2.1) with the 
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following parameters: Top 6 most intense fragments of each peptide were extracted 
from the SWATH data sets (75 ppm mass tolerance, 10 min retention time window). 
Modified peptides (as mentioned above) were included and shared peptides were 
excluded. After data processing, peptides (max 100 peptides per protein) with 
confidence  99% and FDR  1% (based on chromatographic feature after fragment 
extraction) were used for quantitation.  
The extracted SWATH protein peak areas were analysed using APAF in-house 
statistical analysis program. The protein peaks areas were log transformed, normalised 
to the total protein peak area for each run and subjected to one sample t-test to compare 
relative protein peak area between the sample groups (Control vs B7RC2). T-test p-
value smaller than 0.05 and fold change ±1.5 were highlighted as differentially 
expressed proteins. 
3.3 Galectin-1 Knockout methods 
 
3.3.1 Puromycin selection 
Puromycin concentration was optimized prior to CRISPR knockout of HeLa cells by 
growing HeLa cells in a 6 well plate to 80% confluency in antibiotic free DMEM + 
10% FBS. Puromycin was added to each well of the 6 well plate in a range of 
concentrations from 0 µg, 1 µg, 2.5 µg, 5 µg, 7.5 µg and 10 µg/ mL. The plate was left 
to incubate for 5 days and cells were observed every 24 hours. Every 24 hours cells 
were observed visually for signs of death (Cells detaching, rounded cells) and a % of 
live cells were recorded for each well per day. The plate was washed every 48 hours 
and fresh puromycin was added to reduce the number of dead cells in each plate. The 
lowest concentration to kill 100% of the cells in 3 days (2.5 µg) was used in the 
CRISPR knockout experiment. 
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3.3.2 CRISPR Knockout 
CRISPR knockout of HeLa cells was performed in 6 well plates. Confluent HeLa cells 
grown in a T-25 flask were washed in PBS and trypsinised in 0.25% Trypsin 0.02% 
EDTA for 5 minutes at 35°C. Cells were re-suspended in DMEM supplemented with 
10% foetal bovine serum and a 1:1 cell:trypan blue aliquot was placed on a 
heamocytometer to check viability and cell numbers. 1.5 x 105 Cells with > 95% 
viability were aliquoted into 3 mL of DMEM and grown for 24 hours. Transfection 
was performed when the cells reached between 40-80% confluency. Cells were 
washed with PBS and 3 mL of antibiotic free DMEM + 10% FBS was added to the 
cells prior to the start of transfection. 1 µg (25 µL) of galectin-1 plasmid DNA (sc-
400941-NIC, Santa Cruz) was added dropwise to plasmid transfection medium (sc-
108062, Santa Cruz) into a final volume of 150 µL (Reagent A) and left to stand at 
room temperature for 5 minutes. Separately, 5 µL of UltraCruz transfection reagent 
(sc-395739, Santa Cruz) was added dropwise to 145 µL of plasmid transfection 
medium to a final volume of 150 µL (Reagent B) and left to stand at room temperature 
for 5 minutes. Both plasmid DNA and transfection reagent (Reagents A and B) 
solutions were combined (Total 300 µL) after 5 minutes of incubation and vortexed 
before incubating for an additional 20 minutes at room temperature. The total solution 
(300 µL) was then added dropwise to a single well of the 6 well plate and mixed by 
swirling gently. This was repeated 3 times for triplicates, alongside the treatment, 
untreated/ control HeLa cells were grown in the other 3 wells. The 6 well plate was 
incubated at 37°C + 5% CO2 for 24 hours. Media Was then replaced with fresh DMEM 
supplemented with 10% foetal bovine serum (no antibiotics) to remove dead cells and 
then incubated for an additional 24 hours.  Cells were then selected using 2.5 µg of 
puromycin for 48 hours until all cells were dead in the 3 control wells. Cells were then 
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washed and left to grow up to confluency before being split into two T-25 flasks prior 
to Western blot analysis to quantify the effectiveness of the knockout.  
3.3.3 Western blot analysis of knockout 
Western blot analysis of galectin-1 expression was performed on CRISPR gene edited 
HeLa cells as well as control HeLa cells. Confluent HeLa cells were washed twice in 
PBS to remove foetal calf serum and lysed in 200 µL ice cold lysis buffer (1 % SDC, 
0.1 M Triethylammonium bicarbonate, 150 mM NaCl) + 1x Protease Inhibitor cocktail 
(final volume) (P8340 sigma) and left on ice for 1 hour. Lysed cells were scraped with 
a cell scraper for 5 minutes and the accumulated lysate was transferred into a pre-
chilled 1.5 mL Eppendorf tube. The lysate was spun down at 10,000g for 5 minutes at 
4°C to remove bubbles. The lysed samples were then sonicated on ice at 65 ampules 5 
seconds on, 15 seconds off and repeated for a total sonication time of 35 seconds. The 
samples were then spun down at 10,000g for 10 minutes at 4°C and the lysate was 
transferred to new pre-chilled 1.5 mL Eppendorf tubes to remove cellular debris. An 
aliquot from the samples was taken to perform a BSA concentration assay before the 
samples were stored at -80°C. 30 µg of protein from each sample was denatured and 
reduced in 4x Laemmli sample buffer (161-0747 Bio-Rad) supplemented with 10% 2-
Mercaptoethanol (161-0710 Bio-Rad) at a ratio of 3:1 by boiling at 95°C for 7 minutes. 
30 µL of sample was loaded in triplicates onto wells of a 12.5% polyacrylamide gels 
and run in a PROTEAN electrophoresis tank (Bio-Rad) at 100V for 15 minutes 
followed by 130V for 1 hour. Gels, filter paper and nitrocellulose membranes (Bio-
Rad) were soaked in pre-chilled Towbin transfer buffer (25mM Tris, 192 mM Glycine, 
20% methanol, pH 8.3) for 15 minutes. Transfer was performed using a Bio-Rad 
Trans-Blot semi-dry electrophoretic transfer cell (Catalog # 170-3940) by layering 
filter paper, nitrocellulose, gel and filter paper in a sandwich and running for 30 
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minutes at 15 V.  Nitrocellulose membranes were washed in 1X TBST (137 mM NaCl, 
20 mM Tris, 0.1% Tween-20) for 5 minutes and cut into strips at 50 kDa for β-Tubulin 
and 15 kDa for Galectin-1. The membrane strips were blocked in 1 x TBST + 5% skim 
milk for 30 minutes.  The membranes were washed in 1 x TBST for 5 minutes and 
transferred into primary antibody for β-tubulin antibody rabbit IgG (sc-9104, Santa 
Cruz) at a ratio of 1:10000 and galectin-1 antibody (C-8) mouse IgG (Santa Cruz sc-
166618) at a ratio of 1:500 diluted in 1 x TBST. Membranes were incubated in primary 
antibody on ice overnight. Membranes were then washed in 1X TBST for a total of 15 
minutes on a shaker, changing fresh TBST every 5 minutes. The membranes were then 
transferred into secondary antibody and incubated for 3 hours on ice, anti-mouse 
conjugated to horse radish peroxidase (170-6516 Bio-Rad) for galectin-1 at a dilution 
of 1:10000 and anti-rabbit conjugated to horse radish peroxidase (170-6515 Bio-Rad) 
for β-tubulin at a dilution of 1:10000. The membranes were then washed again for 15 
minutes in 1 X TBST changing to fresh TBST every 5 minutes.  200 µL of ECL 
(1705062 Bio-Rad) was added to each of the membranes just before imaging on a 
Chemidoc. Imaging was performed on a Chemidoc imager (BioRad) until the bands 
just reached saturation (1 second for β-tubulin and 30 seconds for Galectin-1). A white 
light exposure was also performed on each strip before both images were merged in 
order to match the ladder to the correlating bands. 
3.3.4 Flow Cytometry  
Flow cytometry analysis was performed on CRISPR gene edited HeLa cells as well as 
control HeLa cells as a secondary validation method. Cells were grown to 80% 
confluency in T-25 flasks and viability was checked using the trypan blue staining 
method mentioned above. Media was removed from the T-25 flasks and the cells were 
washed in 2 mL of 1 x phosphate buffered saline. 1 mL of Trypsin-EDTA (0.25%, 
41 
 
0.02%) was added and the cells were placed in a 35°C incubator for 5 minutes. 
Trypsinised cells were placed in a 15 mL tube and spun down in a centrifuge at 400 g 
for 4 minutes. Cells were gently vortexed while 2 mL of 70% ethanol was added 
dropwise. Cells were stored at 4°C for 24 hours to allow for fixation. Cells were then 
vortexed and spun down at 400 g for 4 minutes again and 70% ethanol supernatant 
was discarded. Cells were resuspended in 2 mL of 1 x PBS prior to flow cytometry 
analysis. Flow cytometry was performed on a BD FACSCanto II flow cytometer 
analyzing 10,000 events, using the following parameters: Forward side scatter (FSC) 
voltage: 240 V, Side Scatter (SSC) voltage: 300, B_530/30: 570 V, V_450/50: 475 V, 
V_510/50: 525 V. Data was collected and analysed using flowing software (Flowing 
software, 2013). 
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Chapter 4: Results 
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4.1 SWATH-MS host parasite interaction study 
 
SWATH-MS analysis of host mammalian cervical epithelial (HeLa) cell samples 
consisting of 3 control T-25 flasks and 3 T-25 treatment flasks resulted in 2651 
proteins quantified across all 6 samples. As shown below in Figure 6, of all the proteins 
quantified, a total of 22 proteins were identified as being differentially expressed in 
the treated group compared to the control. Proteins were considered as differentially 
expressed as either significantly upregulated or downregulated with a fold change of 
± 1.5 (p value <0.05). Table 1 and Table 2 show a list of the 22 proteins that were 
significantly upregulated and downregulated, 8 proteins were identified to be 
upregulated while 14 were identified to be downregulated. Figure 7 shows a heat map 
highlighting that there was a lot of variation of up and down regulated proteins between 
each sample when clustered by euclidean distance.  
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Figure 6. Volcano plot of all 2651 proteins identified in swath analysis, significant 
proteins with a –log10 P-value of <0.05 and a log2 fold change of > - 0.584963 were 
identified as being upregulated while a log2 fold change of > 0.584963 were 
identified as upregulated. 
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Table 1. List of all upregulated proteins identified in HeLa cells following interaction with Trichomonas vaginalis 
Protein Name UniProt 
Code 
Protein Function Fold 
Change 
Up/Down 
Regulated 
Periodic tryptophan protein 1 homolog Q13610 Cell Growth, differentiation 3.569115 UP 
Quinone oxidoreductase PIG3 Q53FA7 Oxidoreductase 3.147761 UP 
von Willebrand factor A domain-containing 
protein 8 
A3KMH1 ATPase activity 1.847819 UP 
Serine protease HTRA2 O43464 Serine Protease, released 
during apoptosis 
1.680249 UP 
N-alpha-acetyltransferase 10 P41227 Acetylates proteins 1.605311 UP 
AP-3 complex subunit beta-1 O00203 Protein sorting of 
transmembrane proteins 
targeted to lysosomes 
1.584637 UP 
Complement component 1 Q subcomponent-
binding protein 
Q07021 Involved in inflammation 
and mediates apoptosis 
1.552889 UP 
YLP motif-containing protein 1 P49750-4 Involved in the reduction of 
telomerase activity 
 1.524129 UP 
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Table 2. List of all downregulated proteins identified in HeLa cells following interaction with Trichomonas vaginalis 
Protein Name UniProt 
Code 
Protein Function Fold 
Change 
Up/Down 
Regulated 
Histone H2B type 2-E Q16778 Component of the nucleosome, involved in 
chromosomal stability, DNA repair and 
replication 
0.66425 DOWN 
Putative RNA-binding protein 
15 
Q96T37 mRNA export factor 0.659121 DOWN 
Ribosomal RNA processing 
protein 1 homolog B 
Q14684 RNA processing 0.633589 DOWN 
Lipase maturation factor 2 Q9BU2
3 
Transmembrane protein involved in lipid 
metabolism 
0.624055 DOWN 
Alkyldihydroxyacetonephosphat
e synthase 
O00116 Lipid biosynthesis 0.616785 DOWN 
40S ribosomal protein S25 P62851 Component of 40S subunit of ribosomes 0.580483 DOWN 
4-hydroxyphenylpyruvate 
dioxygenase-like protein 
Q96IR7 Enzyme involved in tyrosine degradation 0.573365 DOWN 
Exocyst complex component 4 Q96A65 Component of exocyst complex that targets 
vesicles for docking onto the plasma 
membrane 
0.564916 DOWN 
Tyrosyl-DNA phosphodiesterase 
2 
O95551 DNA repair enzyme 0.474183 DOWN 
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Solute carrier family 12 member 
9 
Q9BXP
2 
Subunit of a solute carrier family 0.362638 DOWN 
Uncharacterized protein 
C11orf98 
E9PRG8 Uncharacterised 0.29634 DOWN 
Mitochondrial enolase 
superfamily member 1 
Q7L5Y1 Catabolises L-fucose which is a 
carbohydrate attached to glycoproteins 
0.232111 DOWN 
Peptide deformylase Q9HBH
1 
Deformylates nascent peptides regulating 
ribosomal regulation. 
0.164544 DOWN 
Ubiquitin carboxyl-terminal 
hydrolase 36 
Q9P275 Transcriptional repressor by deubiquiting 
histones at the promoters of genes 
0.024503 DOWN 
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Figure 7. Heatmap of all quantified proteins clustered by Euclidean distance, Red = 
upregulated, blue = downregulated, white = no change. There is significant variation 
between the up and down regulated proteins in each sample, because of this variation the 
experiment should be repeated in an attempt to receive a more uniform trend in the 
results.  
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4.2 Puromycin Optimization 
 
As shown in Figure 8, 2.5 µg of puromycin caused cell death to HeLa cells over the course 
of 72 hours.  Cells were observed as rounded after selection begun, before the majority of 
cells detached at the 48-hour mark and leading to 100% cell death at the 72-hour mark. 
Figure 9 shows control wells over the same time period displaying increased growth, no 
cell death.  
 
 
Figure 8. 2.5 µg of puromycin selecting HeLa cells over 72 hours in a 6 well 
plate. Image are of the 10x objective, by the 72 hour mark all cells have died.  
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Figure 9. 0 µg of puromycin (Control) wells over 72 hours in a 6 well plate. Images are of 
the 10x objective, cells are seen to be growing and becoming overconfluent by 72 hours 
with no sign of cell death. 
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4.3 Galectin-1 Knockout 
 
Western blot analysis was performed on HeLa cells that were treated in a 6 well plate with 
a dual nickase galectin-1 knockout plasmid for 6 hours, after selecting in 2.5 µg/mL of 
puromycin until all control cells were killed in control wells (72 hours). Figure 10 shows 
a reduction of galectin-1 expression in the treated wells when compared to the control 
wells. Densitometry analysis was performed on the average relative density of the western 
blots normalized to the loading control (β-tubulin).  
The density of control blots produced a mean value of 90.97 while the mean treatment 
value was 51.35. A paired student t-test was performed finding a significant difference (p 
< 0.05) in the expression of galectin-1 between the control and treatment groups. Figure 
11 shows there was a significant (p < 0.05) reduction of expression of galectin-1. 
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Figure 10. Western blots comparing control HeLa cells against HeLa cells that were 
treated with a Galectin-1 knockout. 30 µg of protein from control cells were loaded into 
wells 1-3 while 30 µg of protein from treated cells were loaded into wells 4-6. β-tubulin 
was used as a loading control for each western blot experiment. Experiment was 
performed in triplicates and images are of 3 independent replicates. 
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Figure 11. Densitometry analysis of the average of 3 independent replicate western blots 
comparing the relative density of each band normalized against β-tubulin (loading 
control). Average adjusted relative density of the control group was 90.7% while the 
average adjusted relative density of the treatment group was 46.1%. A paired students t-
test was performed finding a significant difference (p <0.05) against the control vs 
treatment group.  
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4.4 Flow Cytometry  
 
Figure 12 shows flow cytometry analysis of green fluorescent protein (GFP) expression 
in Control cells and knockout cell populations analyzing 10,000 events. Both control and 
knockout groups fluoresce when using a 530/30 nm emission filter. There was a slight 
difference in the mean fluorescence of both groups with a mean fluorescence average of 
3490.47 in the control group and 4324.49 in the treatment group. 
 
 
 
Figure 12. Flow cytometry analysis of GFP fluorescence at 530 nm, of control HeLa cells (A) vs 
transfected HeLa cells (B). Histograms of both groups were superimposed to compare the differences 
between each group (C). Images show fluorescence in both the control (HeLa non transfected) and 
treated groups at 530 nm with a slight shift in the mean from 3,490 RFU in the control to 4,324 RFU 
in the treated group.  
55 
 
Chapter 5: 
Discussion 
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5.1 Host-Parasite interaction study using SWATH-MS  
 
The aim of the host parasite interaction study was to use SWATH-MS to identify whether 
the presence of B7RC2 strain T. vaginalis could influence protein expression within host 
cells which may play a key role in the infection process. As shown in Figure 6, there was 
a total of 2651 proteins identified in the SWATH-MS analysis. Of the 2651 proteins, a 
mere 22 were identified as being differentially expressed i.e. significantly upregulated and 
downregulated in the treatment group (interacted) compared to the control. Proteins were 
considered to be differentially expressed, either upregulated or downregulated, with a fold 
change of ± 1.5 and a students t-test p value <0.05. Table 1 shows a total of 8 upregulated 
proteins with fold changes ranging from 3.57 to 1.52 at the protein level. Table 2 shows a 
total of 14 downregulated proteins with fold changes ranging from 0.66425 to 0.024503.  
Periodic tryptophan protein 1 homolog (Pwp1) was the most upregulated in the interaction 
study. Found in the nucleus, Pwp1 is encoded by the PWP1 gene and consists of several 
WD40 repeat proteins. WD40 proteins are abundant throughout the human proteome and 
have been implicated in many biological functions from regulation of transcription, 
apoptosis and signal transduction (Xu & Min 2011). Pwp1 has been found to play a role 
in growth and differentiation. A study by Shen et al (2015) found that Pwp1 expression is 
needed to differentiate mouse embryonic stem cells (mESC) from pluripotent state to all 
other cell lineages. Shen et al (2015) found that knocking down PWP1 affects 
differentiation but not proliferation or apoptosis (Shen et al. 2015). The PWP1 gene is also 
associated with regulating nutrient dependent growth through ribosomal gene expression 
by acting in tandem with the mTOR signaling pathway to regulate transcription factor 2 
(Liu et al. 2017). Liu et al. (2017) found high levels of Pwp1 was associated with a poor 
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prognosis in head and neck squamous cell carcinoma due to the higher rate of ribosome 
biogenesis leading to more aggressive tumors (Liu et al. 2017). The high upregulation of 
Pwp1 in HeLa cells after interaction with T. vaginalis poses an interesting question; is T. 
vaginalis sabotaging its host by signaling as a potential nutrient in order to stimulate 
cellular proliferation? Studies have shown that T. vaginalis secretes molecules such as T. 
vaginalis macrophage migration inhibitory factor (TvMIF), a pro inflammatory cytokine, 
that promotes inflammation and cellular proliferation which may be implicated in an 
increase in prostate cancer risk (Mitteregger et al. 2012; Twu et al. 2014). According to 
Twu et al. (2014) TvMIF mimics human macrophage migration inhibitory factor (HuMIF) 
and stimulates CD74 binding leading to the activation of the Akt/BAD pathway. 
Downstream of the Akt pathway is the mTOR signalling pathway as shown in Figure 13 
that Pwp1 is a member of, although TvMIF and CD74 are not directly implicated in PWP1 
upregulation it may potentially be affected downstream (Liu et al. 2017; Twu et al. 2014). 
As HeLa cells are a cancerous cell line it may potentially be affecting the upregulation of 
Pwp1, Future T. vaginalis interaction studies could look more at the role of host Pwp1 and 
why it may be upregulated, using a primary cell line to distinguish whether the 
upregulation was due to T. vaginalis of it was due to the cancerous cell line.  
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Figure 13. AKT cell signalling pathway and associated downstream pathways including 
the mTOR pathway that Pwp1 is a part of, affecting cellular proliferation as well as 
inflammation. (Bio-Connect 2008).  
Interestingly the 40S ribosomal protein S25 which is a protein that makes up a component 
of the 40S ribosome subunit was found to be downregulated yet it was the only protein 
component of the ribosome to be differentially expressed. 40S ribosomal protein S25 is 
one of 80 distinct proteins that make up the two ribosomal subunits which have function 
as not only ribosome assembly and translation but also have independent functions (Zhou 
et al. 2015). Ribosomal protein S25 is encoded by the gene RPS25 and has been implicated 
in regulating cell signaling pathway MDM2-p53 by suppressing cell proliferation. RPS25 
regulates the ubiquitination of p53 a tumor suppressor by binding to MDM2 preventing 
p53 from being degraded. When cells are in ribosomal stress, which may occur due to the 
cytotoxic effects of T. vaginalis, RPS25 is downregulated in the cytosol leading to the 
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degradation of p53 and thus increased cell proliferation (Zhang et al. 2013). It is not clear 
whether the interaction of T. vaginalis with HeLa cells would have caused this 
downregulation in order to increase the proliferation of cells. It is more likely that this is 
due to HeLa cells being a cancer cell line, and the increased stress caused by the parasites 
lead to this downregulation naturally due to the cancerous nature of the cell line and the 
affected protein pathways (Leroy et al. 2014). Further studies using non-cancerous cell 
lines could be performed to look further into whether the downregulation of Ribosomal 
protein S25 is biologically relevant (Leroy et al. 2014).  
The second most upregulated protein compared to control cells was Quinone 
oxidoreductase PIG3 encoded by the gene TP53I3.  Quinone oxidoreductase PIG3 is an 
enzyme with oxidoreductase activity that is mediated by the tumor suppressor p53, 
responding to cellular stresses such as oxidative stress (Pospisilova et al. 2004). When T. 
vaginalis interacts with host cells, it is able to stimulate the production of proinflammatory 
host cytokines such as IL-1, IL-6, and TNF-α as well as nitric oxide (Han et al. 2009). The 
increase of nitric oxide and cytokines causes stress on the mammalian cells which can 
activate apoptotic pathways such as the expression of Quinone oxidoreductase PIG3 
mediated by p53 which leads to cell apoptosis (Pietsch et al. 2008). The high upregulation 
of Quinone oxidoreductase PIG3 may be due to the response to damage by T. vaginalis 
and the cellular environment activates pathways to kill the respective cells that may be 
beyond repair. Of the proteins identified in this host-parasite interaction study, many were 
related to damage and repair of the mammalian epithelial cells such as the upregulated 
serine protease HTRA2, complement component 1 Q subcomponent binding protein 
(gC1qR) and the downregulated histone H2B type 2-E.  
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Serine protease HTRA2 is an enzyme encoded by the HTRA2 gene and is involved in 
apoptosis. This protease is released in the cytosol where it then contributes to cell death 
via apoptosis (Vande Walle, Lamkanfi & Vandenabeele 2008). HTRA2 can induce 
caspase activity by removing the inhibitors of caspases 3, 7 and 9 through its own 
proteolytic activity. By removing the caspase inhibitors such as XIAP which is bound to 
caspases 3,7 and 9 inhibiting their activity, these caspases become enzymatically active 
leading to apoptosis and cell death (Yang et al. 2003). The upregulation of HTRA2 may 
be due to T. vaginalis cytotoxic effects. A study by Gilbert et al. (2000) suggest that T. 
vaginalis produces contact depended cytotoxic effects including the induction of 
apoptosis. Further studies by Lustig et al. (2013) have shown that cytolysis of both prostate 
and vaginal epithelial cell lines seem to need T. vaginalis to be attached in order to produce 
cytolysis of the cells (i.e. contact dependent). Lustig et al. (2013) blocked the attachment 
of T. vaginalis to epithelial cells by the addition of a 0.4 µm porous membrane which 
allowed any secreted proteins to pass through and found that this blocked the cytolysis of 
the epithelial cells (Lustig et al. 2017).  Studies have also shown protease activity is able 
to initiate apoptosis in host cells. The addition of E-64, a cysteine protease inhibitor, was 
able to inhibit apoptosis of vaginal epithelial cells. This is significant because it is well 
established that T. vaginalis secretes several proteases including cysteine proteases 
including CP30 fraction which consists of CP2, CP3, CP4 and CPT CP2, CP12, CP39, 
and rhomboid proteases (Figueroa-Angulo et al. 2012; Kummer et al. 2008; Riestra et al. 
2015; Sommer et al. 2005). It is likely that the release of these cysteine proteases was 
initiating apoptosis, since the study was performed on HeLa cells in a medium of 1:1 
DMEM: DMM, there iron would have been available in the media. One study by Sommet 
et al (2005) proved that the release of some cysteine proteases from T. vaginalis is 
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modulated by iron availability, reducing the amount of iron increases the release of CP30 
in order to induce apoptosis and inflammation which allows for the uptake of nutrients 
from the host cells. Future studies could look at reducing or increasing iron availability 
while the interaction is performed to see if that has an effect on what proteins are 
upregulated or downregulated in those different environments (Sommet et al. 2005).  
Complement component 1 Q subcomponent binding protein (gC1qR) was upregulated 
and is a protein that is involved in numerous biological functions ranging from ribosome 
biogenesis, apoptosis regulation, and infection/inflammation processes. gC1qR is a 
binding protein involved in the complement system which can trigger chemotaxis and 
phagocytosis. gC1qR can bind to the first component of the complement system C1q to 
stimulate the movement/infiltration of neutrophils (Leigh et al. 1998). GC1qR is 
expressed both in on the surface of the cell as well as intracellularly and can induce the 
production of pro-inflammatory factors such as the activation of the complement system 
as well as generating kinins such as bradykinin to dilate blood vessels and promote 
coagulation (Ghebrehiwet et al. 2006).  Interestingly this protein has been implicated to 
be exploited by many pathogens including viruses, bacteria and parasites such as hepatitis 
C, HIV, Staphylococcus aureus, Listeria monocytogenes and Plasmodium falciparum 
(Braun, Ghebrehiwet & Cossart 2000; Fausther-Bovendo et al. 2010; Nguyen, 
Ghebrehiwet & Peerschke 2000; Pednekar et al. 2016). Pathogens exploit gC1qR to either 
suppress the immune response which increases the likelihood of survival of pathogens or 
they utilize it to crosstalk with the host cells. For example, hepatitis C virus uses a core 
protein HCV to bind to host GC1qR. This suppresses the ability for T cells to proliferate 
thus reducing the impact of the natural immune response against this virus (Pednekar et 
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al. 2016). L. monocytogenes uses host GC1qR as  a receptor for InlB, a surface protein, to 
induce signals and allow cross talk and initiate internalization (Cossart, Pizarro-Cerda & 
Lecuit 2003).  P. falciparum adheres to cell surface GC1qR via a domain on the protein 
called P. falciparum erythrocyte membrane protein 1 (Magallón-Tejada et al. 2016). 
Currently there are no studies exploring the interaction of T. vaginalis and GC1qR yet 
based on interactions with other parasites and pathogens, there could be a potential for T. 
vaginalis to be utilizing cell surface GC1qR to adhere or to promote inflammation. Future 
experiments could look at GC1qR upregulation to verify whether it is consistently 
upregulated and perform a knockout using CRISPR/cas9 and see if it effects T. vaginalis 
attachment to host cells.  
Another protein that was downregulated and related to damage and repair of the host cells 
was Histone H2B type 2-E. Histone type 2-E is a protein that is involved in the 
maintenance of chromosomes by compacting chromatin as well as the repair of DNA 
(Chen-Yi et al. 2011). Histone type 2-E has been proposed to have anti-microbial/fungal 
effects on bacteria and fungi as well as against the parasite Leishmania through 
modulation of the immune response, acting as an antimicrobial peptide (Kawasaki & 
Iwamuro 2008; Wang et al. 2011). As histone type 2-E was found to be downregulated in 
the host cells there is a potential interaction where T. vaginalis is suppressing histone type 
2- E in order to aid its survival by suppressing the innate immune response. Further studies 
into how histones affect and interact with T. vaginalis could be performed in the future.   
The third most upregulated protein was von Willebrand factor A domain- containing 
protein 8 (VWA8). Unfortunately, there is not much known about this protein. A study by 
Luo et al (2017) attempted to characterize this protein  in mouse liver cells and found that 
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it has ATPase activity and functions as enzymes that import metabolites in cellular 
metabolism as well as exporting any toxins out of the cell (Luo et al. 2017). As there is 
little research available on the function of VWA8 it is hard to discern its function in 
relation to the hosts interaction with T. vaginalis. It may be that it is being upregulated to 
export toxins out of the cell created from T. vaginalis release of proteases, such as cysteine 
proteases, metalloproteases and rhomboid proteases which function to lyse the host cells 
(Cardenas-Guerra et al. 2013; Quintas-Granados et al. 2013; Riestra et al. 2015). Further 
studies will need to be performed to understand the full function of VWA8 and whether it 
is consistently upregulated in response to T. vaginalis. 
N-alpha-acetyltransferase 10 (Naa10) was upregulated which is a protein that forms part 
of a complex called NatA acetyltransferase. NatA acetyltransferase is an enzyme that adds 
acetyl groups to proteins formed by ribosomes. Around 80% of proteins found in humans 
are acetylated at the N-terminus (front end) of the protein while 40% are specifically 
acetylated by the Naa10 subunit (Dörfel & Lyon 2015; Foyn et al. 2013). The Naa10 
subunit has many functions including regulating DNA damage repair responses and 
apoptosis, inducing cellular death in response to damage to DNA (Yi et al. 2011; Yi et al. 
2007). As Naa10 was upregulated in response to T. vaginalis, and given that a large 
number of proteins are acetylated, Naa10 is most likely upregulated in order to process 
other proteins that have become or are becoming expressed due to the interaction. Naa10 
may also be upregulated in response to damage by the parasite as part of the process of 
apoptosis.  
AP-3 complex subunit beta-1 (AP3B1) was upregulated which is a subunit of a protein 
involved in protein sorting, especially proteins in organelles and lysosomes 
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(Dell'Angelica, Ooi & Bonifacino 1997). AP3B1 interacts with clathrin which forms 
coated vesicles (Drake, Zhu & Kornfeld 2000).Vesicles play many roles including nutrient 
transfer, cell signaling, and the mediation of the immune response. AP3B1 is a component 
of the AP3 complex that is required for the trafficking of Toll like receptors such as TLR2, 
TLR4 and TLR9 as well as the activation of interleukin 6, a pro inflammatory cytokine, 
as part of the innate immune response (Petnicki-Ocwieja et al. 2015). The upregulation of 
AP3B1 is most likely due to the innate immune response to T. vaginalis in an attempt to 
destroy the parasite. IL-6 has been found to be upregulated by T. vaginalis to produce an 
inflammatory response, as well as other pro inflammatory mediators such as IL-8, IgA, 
IgG and Th1 (Han et al. 2009; Fichorova 2009). T. vaginalis selectively upregulates these 
mediators potentially to exploit and evade the immune system by creating a chaotic 
microenvironment within the host cells. Further studies could be performed to see the 
exact relationship between AP3 and its compartments and T. vaginalis to see whether the 
upregulation of AP3 does in fact aid T. vaginalis or whether it is just the natural response 
of the host bodies towards the parasite. Studies could include generating a knockout of 
AP3 and interacting the knockout with T. vaginalis parasites and studying the impact on 
the immune response.  
Many of the downregulated proteins seem to be affecting the cell’s ability to mature 
proteins including Putative RNA-binding protein 15, Ribsomal RNA processing protein 
1 homolog B, Lipase maturation factor 2, alkyldihydroxyacetonephosphate synthase, 
Tyrosyl-DNA phosphodiesterase 2, solute carrier family 12 member 9, peptide 
deformylase and ubiquitin carboxyl- terminal hydrolase 36. These proteins are normally 
involved in protein synthesis, lipid metabolism and biosynthesis, RNA synthesis and the 
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exportation of mRNA. The downregulation of these proteins is most likely due to stress 
responses on the cells as well as the initiation of apoptosis. Studies have shown that stress 
to cells causes the cells to inhibit protein synthesis either to conserve energy and limit the 
production of proteins to the most vital in order to survive the adverse environmental 
conditions or due to the activation of apoptosis as the cells need to redirect energy to the 
activation of caspases leading to cell death. As shown in Figure 14, there is a balance 
between cell responses to damage, balancing survival and apoptosis through signaling 
cascades leading to survival or cell death (Elmore 2007; Nowsheen & Yang 2012; Peng 
et al. 2007). 
 
 
 
 
 
 
 
 
 
Figure 14. Signaling cascades leading to cell death, cell cycle arrest or transcription 
of survival genes. Host cells balance cell cycle arrest, transcription and cell death 
based on the signaling environment, when caspases are released due to these 
signals it leads to cell death (Nowsheen & Yang 2012). 
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In summary, many of the proteins that were differentially expressed in this host-parasite 
interaction study relate to apoptosis and the induction of immune responses (Serine 
protease HTRA2, Pwp1, Quinoneoxidoreductase PIG3, Naa10, AP3B1 and Histone H2B 
type 2-E) while a small group of proteins seemed to effect proliferation and potential 
attachment of the parasite (gC1qR, Pwp1). The remainder appeared to impact the 
maturation of proteins in response to cellular stress from the parasite. The results have 
generated further questions that could be used in future studies. As the interaction was 
performed for 30 minutes, it could be extended further to see if the protein profile changes 
even more following the establishment of infection. Further studies could also be 
performed on Pwp1 to see if T. vaginalis does try to initiate proliferation in the mammalian 
cells. Further studies on the protein gC1qR could also be performed to see if T. vaginalis 
uses this protein to attach similar to other parasites mentioned above.  
As Figure 7 shows, there was a lot of variation between the samples, in terms of 
upregulated and downregulated proteins. This effects the end result as there seems to be 
many proteins being differentially expressed in all the samples but due to the large 
variation they are not statistically significant, with only 22 proteins that were consistently 
differentially expressed between the control and treatment groups. This experiment should 
be repeated again with 3 independent replicates in order to gain more accurate results.  
Interestingly galectin-1 was identified in the SWATH interaction study but was not 
identified as being differentially expressed (Data in appendix) this could be due to a few 
reasons, galectin-1 is found to be abundant throughout the cell, on the cell surface, in the 
cytoplasm and within the nucleus so T. vaginalis may not necessarily need to upregulate 
galectin-1 to use it as an attachment point onto host cells (Camby et al. 2006) The 
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interaction time may also have been too short to potentially see changes in galectin-1 
expression across the cell and increasing the amount of time T. vaginalis is allowed to 
interact with the cells may start to show changes in galectin-1 expression.  
5.2 SWATH-MS interaction study methodology 
 
The Swath interaction study was performed for 30 minutes and 5 x 104 parasites/ ml of 
parasites were chosen as a baseline with the view to increase the time as well as 
concentration of parasites in further SWATH experiments. 5 x 104 parasites/ ml (Ratio of 
1:5 parasites/ HeLa cells) was chosen as a baseline as many previous works have used 
ratios ranging from low (1:5) all the way to high (30:1) (Dias-Lopes et al. 2017; Kim et 
al. 2017; Salvador-Membreve, Jacinto & Rivera 2014; Vilela & Benchimol 2011). Due to 
the variation of attachment ratios and times, the interaction time and the number of 
parasites was chosen based on previous literature. A study by Kucknoor, Mundodi & 
Aldarete (2005) studying the differential expression of genes in vaginal epithelial cells 
after interacting T. vaginalis concluded after optimizing an adherence assay, that a 30-
minute interaction time was the most ideal. Kucknoor, Mundodi & Aldarete (2005) found 
that T. vaginalis would adhere to the cell monolayer within 15 minutes, however, at 45 
minutes disruption of the monolayer and significant cytotoxicity would occur. Many other 
studies vary in their interaction times ranging from 30 minutes to days. Due to this fact, 
30 minutes was chosen with the view to increase the interaction time in future experiments 
(Dias-Lopes et al. 2017; Kim et al. 2017; Salvador-Membreve, Jacinto & Rivera 2014; 
Vilela & Benchimol 2011). A low parasite to cell ratio was chosen with the view to 
decrease the cytotoxic effects of the parasites on the cells, for example using a high 
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number would increase the number of proteases released causing damage to the cells at a 
faster rate and impacting what proteins would be seen as upregulated or downregulated.  
A study by Lustig et al (2013) that looked at contact dependent cytolysis of epithelial cells 
and interacted 23 different strains of T. vaginalis found that there was a significant amount 
of variation of attachment and cytolysis between the strains. Lustig et al (2013) also found 
that there was a significant correlation between lowly adherent T. vaginalis strains and 
higher cytotoxity but higher adherent strains did not see this same correlation. The parasite 
that was used in this experiment was a highly adherent strain (B7RC2) while a colleague 
used a lowly adherent strain (PRA98) in tandem however due to a budget constraint only 
9 samples could be performed, 3 B7RC2, 3 PRA98 and 3 controls, based on the increased 
cytotoxity the lowly adherent strain would have on the cells the lowest time point was 
used. Interestingly many more proteins were found to be differentially expressed in the 
colleague’s strain (Data shown in appendix).  Using a 30-minute interaction time and an 
MOI of 1:5 parasites/ HeLa cells this experiment could be used as a baseline with a view 
of increasing time and number of parasites in further experiments which would give a 
greater view on what host proteins are differentially expressed from the initiation of 
attachment (30 minutes) to much longer times.  
HeLa cells were chosen as they were the only available vaginal epithelial cells, VK2 E6E7 
cells were initially going to be used but were unable to be revived and due to budget and 
time restrictions no more could be acquired.  HeLa cells were then chosen as a backup as 
they were available and have been previously used in other T. vaginalis studies. HeLa 
cells have been used in many host parasite interaction studies involving T. vaginalis from 
studies performed in 1985 that looked at T. vaginalis attachment until now where more 
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recent studies looking at drug candidates that may be active against T. vaginalis (Alderete 
& Garza 1985; Mandalapu et al. 2016; Vieira et al. 2016). In future experiments, it would 
be ideal to use another cell line such as VK2/E6E7 as they are closer to the legitimate 
environment that T. vaginalis would live in as these cells are vaginal epithelial cells while 
HeLa are cervical epithelial cells (Fichorova et al. 2016). Interacting T. vaginalis with a 
prostate epithelial cell line would also be ideal due to the fact that T. vaginalis infects both 
male and females.   
5.3 Galectin-1 Knockout 
 
The aim of the galectin-1 knockout proof of principle study was to generate a complete 
knockout of galectin-1 to use in future experiments. As shown in the Figures 10 and 11, 
the complete knockout of galectin-1 was unsuccessful. As Figure 10 demonstrates, there 
was a reduction of galectin-1 expression following western blot analysis. Although there 
is a reduction, partial expression is still revealed of galectin-1 after performing the 
CRISPR knockout. Densitometry was performed on the western blots in order to quantify 
whether there was a significant reduction of galectin-1 when normalized to a loading 
control (β-tubulin). As Figure 10 shows, there was a significant reduction of the 
expression of galectin-1 with an adjusted relative density for the control group of 90.7% 
and 46.1% for the treatment group respectively. A paired t-test was performed on the 
average of the triplicate western blots which showed there was a significant difference 
between the two groups (p <0.05). This shows there is a reduction of galectin-1 expression 
within the HeLa cell population but galectin-1 is still expressed either at a lower amount 
or in some cells in the population. There are multiple factors that may be at play as to why 
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a complete knockout of galectin-1 was unable to be produced. These may include the 
CRISPR plasmid used, technique, available equipment and wild type contamination. 
When attempting a complete knockout of a gene, the sequence of the CRISPR gRNA is 
an important factor in whether the product will be able to generate a complete knockout. 
The gRNA sequences determine where insertions or deletions will occur, directing Cas9 
to the target and introducing a double strand break. The sequence must also be adjacent 
and upstream of  a protospacer adjacent motif (PAM) (Cencic et al. 2014).  For a complete 
knockout the sequences must delete part of an exon causing a frameshift mutation after 
non homologous end joining repair pathway, that will cause the protein to be misfolded 
and degraded or by destroying the exon/ intron junction so that the protein may not be 
expressed (Bauer, Canver & Orkin 2015). If the sequences completely splice out an exon 
but the open reading frame remains intact, isoforms of the protein may then be produced 
which may be detected by the galectin-1 antibody. The guide RNA sequences in the dual 
nickase CRISPR plasmid used in the knockout for LGALS1 (sc-400941-NIC Santa Cruz) 
were GGAGAGTGCCTTCGAGTGCG and AGGTTTGAGATTCAGGTTGC. When 
querying the sgRNA sequences using E-CRISP (Heigwer et al. 2014) to validate the 
sequences it was found that AGGTTTGAGATTCAGGTTGC targets the negative sense 
strand with a specificity score of 40, annotated score of 54.6 and an efficiency score of 
33. The Doench et al (2014) score was 0.024 and Xu et al (2015) score was 0.0734229352. 
GGAGAGTGCCTTCGAGTGCG targets the positive sense strand with a specificity score 
of 40, annotated score of 52.8 and an efficacy score of 70.3. The Doench et al (2014) score 
was 0.56 and Xu et al (2015) score was 0.2551392616. According to the queried results, 
despite the low efficiency and specificity score, the sgRNA should be targeting all 4 exons 
leading to a complete knockout of galectin-1. The Doench scores gives a score based on 
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on-target effects to calculate how well an sgRNA will function at its specific site. The 
higher the Doench score and Xu score the higher the chance of the sgRNA targeting its 
specific site with higher efficiency and less off target effects. When screening LGALS1 
for sgRNA sites using E-CRISP evaluation tool there were many sgRNA sequences that 
had higher Doench and Xu scores while also having higher specificity, annotated and 
efficacy scores. For example, the minus sense strand CACAAGCCATGATTGAGTCC 
specificity score of 40, annotated score of 81, efficacy score of 37 plus Doench score of 
0.084 and a Xu score of 0.267. This would be a better sgRNA sequence to use in place of 
the lower scoring minus sense strand used in the pre made Santa Cruz product and 
designing and making our own plasmid may produce better results although it would 
require a longer process of design and validation of the sequences and plasmid (Heigwer, 
Kerr & Boutros 2014).  
There are factors other than the product that also could be causing the incomplete 
knockout such as the techniques used. The knockout of galectin-1 on mammalian HeLa 
cells was performed in accordance to the protocol provided by Santa Cruz, first by 
optimizing puromycin amounts to obtain the lowest concentration of puromycin that kills 
100% of non-transfected cells in 3-5 days. Figure 8 shows the use of 2.5 µg of puromycin 
which was able to kill 100% of the cells within 72 hours compared to a control plate of 0 
µg shown in figure 9. Secondly transfection reagent amounts were optimized, when 
performing initial experiments, the cells would all die higher than 5 µl of transfection 
reagent. A similar problem occurred when using higher than 1 µg of plasmid DNA so that 
was chosen as a baseline. For the amount of time to transfect, it was found that following 
Santa Cruz’ protocol to transfect for 24-72 hours would also kill all the cells so the time 
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was reduced until cells were seen to be alive (6 hours of transfection). The number of cells 
that did survive was minimal after transfection, with only about 10% of the initial cells 
surviving.  Puromycin selection was then performed on these cells, in conjunction with 
control wells and puromycin selection was not stopped until 100% of the cells in the 
control wells were dead. The cells were left to grow to confluency which took a few weeks 
of slow growth before there was enough to expand to T-25 and T-75 flasks to perform 
western blot analysis.  Flow cytometry was also utilized as the plasmid has both a green 
fluorescence protein (GFP) marker and puromycin marker. As shown in Figure 12, HeLa 
seems to auto fluoresce at the same wavelength of GFP used in the experiment (530 nm) 
There was a slight difference in the mean fluorescence of both groups with a mean 
fluorescence average of 3490.47 in the control group and 4324.49 in the treatment group 
meaning there was a slight increase in fluorescence caused by GFP between the control 
and treatment groups but we could not use this data to accurately confirm all cells in the 
population were transfected. Due to a lack of a cell sorter, sorting of GFP expressing cells 
could not be performed which would of greatly increased the chances of selecting only 
positively transfected cells (Bauer, Canver & Orkin 2015). Normally PCR would also be 
performed on the cells to confirm the knockout on a genomic scale and to positively select 
for 100% homozygous clones where all the alleles of the target gene have been edited, as 
there may be a heterozygous population of cells. Due to a restricted budget only western 
blotting was used but PCR should be used in conjunction in future knockout attempts.  If 
the population are heterozygous there will still be an expression of galectin-1 which would 
be detected by western blotting. As Figure 15 shows, PCR or mismatch cleavage assays 
can be used to positively select for homozygous populations, PCR product should 
decrease if the cells are positively edited (Ran et al. 2013).  
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Figure 15. Mismatch cleavage assay and PCR to detect for the presence of positive clones 
within a mixed population. These techniques are able to increase knockout success by 
selecting for clones that have both alleles knocked out (Addgene 2015). 
Once PCR has been performed and homozygous populations are identified, these can be 
serial diluted to single colonies which can then be grown up in order to gain a complete 
homozygous cell line. Western blot can be performed to validate the lack of galectin-1 
expression. Studies have knocked out galectin-1 in mice so the large amount of death seen 
in the transfection stage and the unsuccessful complete knockout of galectin-1 should not 
be due to galectin-1 being a critical protein and should be able to be completely knocked 
out (Case et al. 2007; Clark, Weston & Foster 2013; Szebeni et al. 2012).  
Although there was no complete knockout, the significant reduction seen in galectin-1 
expression means that the cell population could still potentially be used in further studies 
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to see how galectin-1 expression impacts the ability for T. vaginalis to attach to its host. 
A study by Okumura, Baum & Johnson (2008) demonstrated that a reduction of galectin-
1 was able to reduce the parasites ability to bind to the host cells. This study used siRNA 
to partially reduce the expression of galectin-1 in ectocervical, endocervical and HeLa cell 
lines (Okumura, Baum & Johnson 2008). As Figure 10 shows, there was quite a significant 
reduction in galectin-1 expression in the HeLa cell line, which might show interesting 
results if T. vaginalis was interacted with this knockout cell line.  
In summary, to further optimize the knockout for future experiments it would be ideal to 
design sgRNA targets that are more likely to have a higher efficiency and have better on 
target effects. After transfection but before selection the cells should be sorted through a 
cell sorter to sort for positive GFP expression, and use a different fluorescent marker 
instead of GFP when using HeLa cells such as cyan fluorescent protein (CFP). The cells 
should then be selected for using puromycin and then analysed using PCR to ensure for 
heterozygous populations. At this point the cells should then be serial diluted and 
expanded before being analysed using western blot to validate that there is a complete 
knockout of galectin-1 expression in the cell line.  Although this method is more time 
consuming and costly there is a higher chance of generating a complete knockout in a 
stable cell line to be used for future experiments.  
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Chapter 6: Future 
Directions 
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6.1 SWATH-MS interaction study 
 
The results discussed above lead to a few potential directions for further studies. Firstly, 
the SWATH interaction study performed for 30 minutes with 5 x 104 parasites / mL (1:5 
MOI) should be repeated to obtain independent replicates to strengthen the evidence of 
what proteins are differentially expressed at this timepoint and to confirm that the proteins 
were differentially expressed due to interaction of the host cells with the parasite. Further 
SWATH experiments could also be performed increasing the amount of time that the 
parasites can attach for to see if the protein profile changes the longer the parasites are 
attached. The same interaction time (30 minutes) could be used while increasing the 
number of parasites to see if that changes the expression profile of the mammalian host 
cells. Finally, these experiments could be performed with different strains of the parasite 
as different T. vaginalis strains have different rates of attachment and cytotoxicity to host 
cells and thus they would most likely have a unique impact of the protein profile of the 
host cells (Kucknoor, Mundodi & Alderete 2005).  
The proteins that were identified in the study to be differentially expressed could also be 
studied further to see how T. vaginalis manipulates the proteins in the host and what T. 
vaginalis utilizes the protein for. For example, the most interesting differentially 
expressed proteins are periodic tryptophan protein 1 homolog (Pwp1), serine protease 
HTRA2 and complement component 1 q subcomponent-binding protein (gC1qR). Studies 
could be performed to explore Pwp1 upregulation to see if T. vaginalis upregulates Pwp1 
to promote proliferation of the host cells. Host cells could be interacted with T. vaginalis 
for a longer period of time e.g. a few days to a week to see if the host cells eventually 
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proliferate or if they all end up dying due to the parasites cytotoxicity to the cells. The 
experiment could be performed in conjunction with a cell line that has a knockout or 
knockdown of PWP1 to see if there is any difference in proliferation. A study exploring 
serine protease HTRA2 expression could be performed by knocking out HTRA2 and 
seeing if it effects caspase activity. T. vaginalis could be interacted with the knockout cells 
to see if it effects the parasites survival. Future studies could also look at reducing or 
increasing iron availability while T. vaginalis is interacted to see if this causes T. vaginalis 
to increase its cytotoxic effects in order to cause inflammation and gain nutrients from the 
environment. Finally, a study could be performed to explore complement component 1 q 
subcomponent-binding protein (gC1qR). A knockout or knockdown reducing gC1qR 
expression could be performed and then interacted with T. vaginalis to see if this effects 
the ability for T. vaginalis to attach to the host cells.  
6.2 Galectin-1 knockout 
 
As discussed above, an incomplete knockout of galectin-1 expression was produced and 
is most likely due to a mixed cell population. In order to generate a complete knockout, 
the knockout experiment could be performed again with plasmids that have more efficient 
sgRNA, the knockout cells could then be analyzed using flow cytometry and sorted by 
GFP expression or another fluorescent marker that does not clash with HeLa auto 
fluorescence. The sorted cells could then be selected with puromycin and grown. PCR 
could then be performed on the cell lines produced by cell sorting to detect for genomic 
deletions and validate a homozygous deletion. Validated homozygous populations can be 
serial diluted and then expanded so that the cell population grew from a single cell thus 
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there should only be homozygous cells in the population once grown. Western blot 
analysis can then be performed to validate the knockout to validate the complete knockout 
of protein expression of galectin-1.  
Once a complete knockout of galectin-1 is generated, the knockout cell line could be used 
in a host-parasite interaction study to explore the effects of the knockout on T. vaginalis 
ability to attach to host cells. T. vaginalis could be interacted with a control cell line for a 
period of time before the number of parasites that are attached are counted. This can be 
repeated on the knockout cell line to then compare whether there was a significant 
reduction of T. vaginalis attachment to the host cells.  
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Chapter 7: 
Conclusion 
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7.1 Conclusion 
In conclusion, the aim of this study consisted of two parts; Aim 1: To investigate changes 
in protein expression in host mammalian cervical epithelial cells following direct 
interaction of T. vaginalis parasites and HeLa cells. Aim 2: A proof of concept study, to 
successfully knockout host galectin-1 using CRISPR/ Cas9 technology.  
This study investigated changes in the protein expression of host mammalian epithelial 
cells following direct interaction of T. vaginalis parasites and HeLa cells. The study 
identified 22 proteins that were significantly upregulated and downregulated, 8 proteins 
were identified to be upregulated while 14 were identified to be downregulated.  Many of 
the proteins identified were related to apoptosis, inflammation, downregulating the 
maturation of proteins as the host cells respond to the cytoxic effects of T. vaginalis. The 
most interesting changes in protein expression were the upregulation of periodic 
tryptophan protein 1 homolog, serine protease HTRA2 and complement component 1 q 
subcomponent-binding protein. Further interaction studies could be performed to explore 
the biological significance of these upregulated proteins potentially finding a therapeutic 
target to combat T. vaginalis infection.  
The proof of concept study with the aim to successfully knockout host galectin-1 using 
CRISPR/Cas9 technology was only able to produce a knockdown of galectin-1 as 
galectin-1 was still being expressed by the HeLa cells. The knockout could be improved 
by implementing further techniques that would increase the chances off a successful 
knockout. This includes cell sorting the transfected cells, validating the knockout with 
PCR and serial diluting and growing up homozygous clonal cell lines. This knockout 
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could then be used in a future interaction study to explore the impact of galectin-1 on T. 
vaginalis parasite adhesion.  
Combined, this study provides further knowledge of T. vaginalis host- parasite 
interactions and provides insights that could be used in future interaction studies.  
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Appendix A 
 
SWATH-MS APAF results  
 
https://www.dropbox.com/sh/emtyjebsegwz0ut/AACGmjUZ1FB-K9soa8Ri7Y7Ia?dl=0 
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